Anticoagulant activity of apixaban can be estimated by multiple regression analysis
Abstract Background Information on apixaban anticoagulant activity is required to prevent major bleeding or thrombosis during its use. Methods We enrolled 194 patients with nonvalvular atrial fibrillation (NVAF) in whom warfarin was replaced with apixaban: 105 (54.1%) received the standard dose of a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-12-01
|
| Series: | Journal of Arrhythmia |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/joa3.12435 |